W&W needed more than devices-they needed secure, flexible technology that empowers mobile sales teams to work safely from ...
AUCATZYL (obecabtagene autoleucel) net product revenue of $23.3 million* for the fourth quarter of 2025 and $74.3 million* for the full year of 2025AUCATZYL UK launch underway following successful Nat ...